Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

NYSE:EXK - New York Stock Exchange, Inc. - CA29258Y1034 - Common Stock - Currency: USD

3.61  +0.09 (+2.56%)

After market: 3.6 -0.01 (-0.28%)

Fundamental Rating

4

EXK gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. EXK may be in some trouble as it scores bad on both profitability and health. EXK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year EXK has reported negative net income.
In the past year EXK had a positive cash flow from operations.
Of the past 5 years EXK 4 years were profitable.
Each year in the past 5 years EXK had a positive operating cash flow.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

EXK has a Return On Assets of -4.38%. This is in the lower half of the industry: EXK underperforms 60.39% of its industry peers.
EXK has a Return On Equity (-6.50%) which is in line with its industry peers.
EXK's Return On Invested Capital of 1.05% is in line compared to the rest of the industry. EXK outperforms 46.10% of its industry peers.
EXK had an Average Return On Invested Capital over the past 3 years of 2.76%. This is significantly below the industry average of 8.82%.
Industry RankSector Rank
ROA -4.38%
ROE -6.5%
ROIC 1.05%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

EXK has a Operating Margin of 3.91%. This is comparable to the rest of the industry: EXK outperforms 53.90% of its industry peers.
In the last couple of years the Operating Margin of EXK has declined.
Looking at the Gross Margin, with a value of 19.33%, EXK is in line with its industry, outperforming 54.55% of the companies in the same industry.
EXK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.91%
PM (TTM) N/A
GM 19.33%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

3

2. Health

2.1 Basic Checks

EXK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EXK has more shares outstanding than it did 1 year ago.
EXK has more shares outstanding than it did 5 years ago.
EXK has a worse debt/assets ratio than last year.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.22 indicates that EXK is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.22, EXK is in line with its industry, outperforming 49.35% of the companies in the same industry.
EXK has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.24, EXK is in line with its industry, outperforming 46.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC0.12
WACC8.82%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

EXK has a Current Ratio of 2.00. This is a normal value and indicates that EXK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.00, EXK is in line with its industry, outperforming 44.16% of the companies in the same industry.
EXK has a Quick Ratio of 1.54. This is a normal value and indicates that EXK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.54, EXK is in line with its industry, outperforming 51.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.54
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

EXK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -250.00%.
The Revenue has been growing slightly by 5.93% in the past year.
EXK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.33% yearly.
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%-0.35%

3.2 Future

The Earnings Per Share is expected to grow by 7.79% on average over the next years.
Based on estimates for the next years, EXK will show a very strong growth in Revenue. The Revenue will grow by 28.76% on average per year.
EPS Next Y342.4%
EPS Next 2Y179.42%
EPS Next 3Y74.85%
EPS Next 5Y7.79%
Revenue Next Year94.75%
Revenue Next 2Y70.46%
Revenue Next 3Y33.75%
Revenue Next 5Y28.76%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

EXK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 7.77, the valuation of EXK can be described as very cheap.
EXK's Price/Forward Earnings ratio is rather cheap when compared to the industry. EXK is cheaper than 85.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. EXK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.77
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

EXK's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.73
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXK's earnings are expected to grow with 74.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y179.42%
EPS Next 3Y74.85%

0

5. Dividend

5.1 Amount

No dividends for EXK!.
Industry RankSector Rank
Dividend Yield N/A

ENDEAVOUR SILVER CORP

NYSE:EXK (5/23/2025, 9:31:00 PM)

After market: 3.6 -0.01 (-0.28%)

3.61

+0.09 (+2.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners44.52%
Inst Owner Change4.73%
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap1.05B
Analysts78.18
Price Target6.11 (69.25%)
Short Float %6.25%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-881.25%
Min EPS beat(2)-1981.29%
Max EPS beat(2)218.79%
EPS beat(4)1
Avg EPS beat(4)-594.65%
Min EPS beat(4)-1981.29%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-322.02%
EPS beat(12)3
Avg EPS beat(12)-264.31%
EPS beat(16)4
Avg EPS beat(16)-217.33%
Revenue beat(2)1
Avg Revenue beat(2)-5.07%
Min Revenue beat(2)-16.69%
Max Revenue beat(2)6.54%
Revenue beat(4)3
Avg Revenue beat(4)1.4%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)14.94%
Revenue beat(8)5
Avg Revenue beat(8)-1.76%
Revenue beat(12)7
Avg Revenue beat(12)-1.19%
Revenue beat(16)7
Avg Revenue beat(16)-3.78%
PT rev (1m)4.67%
PT rev (3m)4.72%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)150%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.43%
Revenue NY rev (1m)24.53%
Revenue NY rev (3m)20.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.77
P/S 4.56
P/FCF N/A
P/OCF 51.98
P/B 2.05
P/tB 2.05
EV/EBITDA 24.73
EPS(TTM)-0.07
EYN/A
EPS(NY)0.46
Fwd EY12.87%
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)0.07
OCFY1.92%
SpS0.79
BVpS1.76
TBVpS1.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.38%
ROE -6.5%
ROCE 1.33%
ROIC 1.05%
ROICexc 1.26%
ROICexgc 1.26%
OM 3.91%
PM (TTM) N/A
GM 19.33%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexcg growth 3Y-31.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 2.9
Cap/Depr 627.73%
Cap/Sales 89.78%
Interest Coverage 2.04
Cash Conversion 48.22%
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.54
Altman-Z 2.22
F-Score4
WACC8.82%
ROIC/WACC0.12
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y342.4%
EPS Next 2Y179.42%
EPS Next 3Y74.85%
EPS Next 5Y7.79%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%-0.35%
Revenue Next Year94.75%
Revenue Next 2Y70.46%
Revenue Next 3Y33.75%
Revenue Next 5Y28.76%
EBIT growth 1Y-2.16%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year213.25%
EBIT Next 3Y71.24%
EBIT Next 5Y58.29%
FCF growth 1Y-66.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.37%
OCF growth 3Y-6.61%
OCF growth 5YN/A